A suspicious order report is a federal reporting obligation, not an internal alert that stays inside a monitoring dashboard. Under 21 CFR 1301.74(b), a DEA registrant that identifies an order of unusual size, an order deviating substantially from a normal pattern, or an order of unusual frequency must inform the local DEA Field Division Office. Having suspicious order monitoring software in place satisfies only half of the rule. What determines whether a flagged order becomes a problem in a later DEA inspection or registration action is the written record the pharmacy built when the order was held, questioned, or shipped.
What Makes an Order Suspicious
Section 1301.74(b) defines a suspicious order by three characteristics: unusual size, substantially larger than the customer's typical order; a pattern that deviates from the norm, a shift in drug mix or ratio of controlled to non-controlled products; and unusual frequency, orders placed closer together than the customer's buying history supports. None of these turns on a fixed numeric threshold set by DEA. The agency has maintained that registrants, not DEA, set and defend their own thresholds based on each customer's ordering history and patient population.
The Reporting Obligation Under 21 CFR 1301.74(b)
The direct reporting duty in 1301.74(b) runs to registrants that supply other DEA registrants, principally distributors and manufacturers, along with pharmacies functioning in that same non-practitioner capacity, for example a central-fill or long-term-care pharmacy shipping to other registered locations. The current reporting channel is the Suspicious Orders Report System (SORS) Online, the centralized database DEA's Diversion Control Division launched in 2019 under the SUPPORT Act. Filing through SORS Online satisfies the requirement to notify both the DEA Administrator and the Special Agent in Charge of the registrant's local Field Division Office in one submission. DEA reopened the information collection tied to this reporting requirement again in 2026, confirming the system remains the operative channel.
When the Pharmacy Is the One Flagged
Most community and retail pharmacies encounter suspicious order reporting from the other side of the transaction. A wholesale distributor's own monitoring system flags one of the pharmacy's purchase orders, and the distributor holds or declines to ship it pending an explanation. That hold can arrive as a due diligence questionnaire asking about patient volume, new prescriber relationships, or a seasonal shift in demand. How the pharmacy responds, and what it keeps in its file afterward, is what a distributor, and later a DEA investigator, looks to first if the same pattern recurs.
Documenting Due Diligence on a Flagged Order
A due diligence file that holds up months or years later contains the specific facts that explain the order at the time it was placed, not a reconstruction written after an inspection notice arrives. That file should include the underlying business reason for the size, pattern, or frequency change, such as a new long-term-care contract or an added prescriber; supporting dispensing and patient records that corroborate the volume claimed; and an inventory reconciliation showing the additional stock was dispensed, not diverted. The decision to hold or ship the order, and who made that call, should be recorded in writing when it happened, not reconstructed from memory later.
A suspicious order report satisfies the regulation. The due diligence file the pharmacy keeps afterward is what satisfies the investigator.
What an Undocumented Pattern Becomes
A single flagged order rarely ends a registration on its own. A pattern of flagged orders with no supporting file behind it is a different matter. Investigators build DEA order to show cause proceedings, and in the most severe cases an immediate suspension order, around exactly this kind of unexplained purchasing pattern. See our companion pieces on responding to a DEA order to show cause, a pharmacy's rights during a DEA inspection, and the audit-ready controlled substance file for the recordkeeping that keeps a flagged order from becoming a registration action.
Why Early Legal Counsel Is Critical
It is critical that pharmacies retain experienced healthcare defense counsel promptly upon receiving a distributor due diligence request or a DEA inquiry about ordering patterns. Early legal intervention can protect the pharmacy's rights, ensure the response is built on documentation that will withstand later scrutiny, avoid inadvertent admissions, and preserve defenses that are available at the outset but foreclosed once an order to show cause has already been issued. Delaying counsel until a pattern of flagged orders has developed can significantly narrow the pharmacy's options.
How Health Law Alliance Can Help
Health Law Alliance defends pharmacies nationwide in DEA registration and inspection matters, including disputes that begin with a distributor's suspicious order hold or a DEA inquiry into ordering patterns. Our bench includes a former federal prosecutor, background that shapes how we build the due diligence record a pharmacy needs before a flagged order draws further scrutiny. If your pharmacy has had an order held, questioned, or reported as suspicious, contact us for a free, confidential consultation.
